mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.4 |